newsfilter
← Latest News
GlobeNewswire·

eFFECTOR Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Presented positive interim results at ASCO 2022 from ongoing zotatifin Phase 1/2 dose escalation and expansion trial Appointed Doug Warner, M.D., as chief medical officer SAN DIEGO and REDWOOD CITY, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- e